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In a relatively small sample this meta-analysis shows fatigue severity improved after activity 1 
pacing interventions and provides a basis to integrate activity pacing in activity stimulation 2 
programs for persons with chronic conditions. 3 
 Activity pacing can feasibly be implemented within standard health care to manage 4 























A meta-analysis was conducted to (1) determine the effect of activity pacing interventions on 1 
fatigue, physical functioning and physical activity among patients with chronic conditions 2 
associated with fatigue complaints, and to (2) examine potential moderator effects of trial 3 
characteristics (components of intervention and amount of patient-provider contact). Six 4 
studies were included in the meta-analysis. Relevant content of the studies was extracted and 5 
rated on methodological quality. Random-effects modelling was used to pool data across 6 
studies. Medium (standardised mean difference = 0.50) and marginal (standardised mean 7 
difference = 0.34) effects were found for fatigue at post-treatment and follow-up respectively. 8 
Inconsequential effects were found for physical functioning and activity (standardised mean 9 
difference = 0.08 to 0.30) at both assessment points. Subgroup analyses revealed components 10 
of intervention and amount of patient-provider contact were not source of variance. Minimal 11 
patient-provider contact had effect on fatigue comparable in magnitude to more intensive 12 
contact. This meta-analysis of activity pacing in patients with fatigue complaints suggests that 13 
activity pacing might have sustained beneficial effects on fatigue management, in particular on 14 
fatigue reduction. The divergence in effects for all outcomes suggests that alternative ways 15 
such as tailoring advice to individual’s behaviour towards physical activity may be more 16 
successful.  17 
Keyword: Activity pacing, fatigue, physical functioning, physical activity, chronic conditions 18 
Introduction 19 
Promoting physical activity is essential to preserve the health, quality of life and physical 20 
functioning of healthy individuals and those with chronic diseases [1-3]. Post-exertional fatigue 21 
is a normal perceptual response in healthy humans but may be exacerbated in patients with 22 
chronically fatiguing conditions such as chronic fatigue syndrome, cancer, fibromyalgia and 23 
osteoarthritis [4,5,6]. Feelings of fatigue (subjective sensations of weariness) is a common 24 
symptom in chronically fatiguing conditions [4,5,6]. Post-exertional fatigue may be a barrier 25 
to physical activity and explain activity avoidance in patients with chronically fatiguing 26 
conditions [6]. 27 
Fatigue may result in cycles of over-activity followed by periods of fatigue-induced inactivity 28 
[7] and activity avoidance, negatively affecting patients’ physical health and quality of life of 29 
patients with chronically fatiguing conditions [6,8]. Fatigue management is therefore 30 
paramount when programming physical activity for patients with conditions characterised by 31 
heightened perceptions of fatigue or pain [9]. 32 
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Activity pacing is a strategy to divide one’s daily activities into smaller, more manageable, 1 
portions, in a way that should not exacerbate their symptoms, which then allows gradual 2 
progressive increases in physical activity [8,10,11]. The goals of activity pacing are to 3 
disentangle the symptom experience from the activity experience, prevent over-exertion, 4 
attenuate fluctuations in physical activity patterns and avert the detriment associated with 5 
fatigue-induced inactivity [8]. While activity pacing is a highly endorsed clinical treatment 6 
strategy in chronic pain [9], it remains poorly researched with very little literature in chronic 7 
fatigue. 8 
The results of the few studies on activity pacing effects in chronic fatiguing conditions have 9 
been conflicting. While one study supported links between pacing and lower levels of fatigue 10 
and higher physical functioning [12], a number of studies have found no association [13,14,15]. 11 
Consideration of these findings highlights uncertainty and confusion about the effect of activity 12 
pacing on fatigue, physical functioning and activity in chronic fatigue. 13 
The aims of the meta-analysis are thus: 1) To review literature on activity pacing interventions 14 
and to determine the overall effect of activity pacing interventions on fatigue, physical 15 
functioning and activity; both at post-treatment and follow-up, among patients with chronic 16 
conditions associated with fatigue complaints; 2) To examine possible moderators such as 17 
components of intervention arm, provider-patient contact frequency, the type of condition and 18 
gender type of the sample.  19 
Methods 20 
This meta-analysis was completed in accordance with the Preferred Reporting Items for 21 
Systematic Reviews and Meta-Analyses statement [16]. 22 
Inclusion criteria 23 
Types of participants 24 
Studies were included if they were conducted in a participant group of adults (≥16years), with 25 
a chronic condition associated with fatigue complaints and fatigue was measured before and 26 
after the intervention. 27 
Types of interventions 28 
Studies had to include a construct of activity pacing that measured patient behaviour, targeting 29 
fatigue management, physical activity and/or physical functioning. 30 
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Outcome measures 1 
Studies had to present statistical data allowing the calculation of effect sizes in the published 2 
study or provided by the author(s) upon request, on at least one of the following outcomes; 3 
fatigue, physical activity and/or physical functioning, measured at baseline (pre-treatment), at 4 
post-treatment and/or at follow-up..  5 
Study Design 6 
Studies had to include a control condition, consisting of usual care, waiting list control, or 7 
another type of intervention (e.g. relaxation). 8 
Studies were included if they were randomized controlled trials published in peer review 9 
journals in English. There were no restrictions with respect to the type of diagnostic criteria 10 
used, setting, format and source of delivery of the intervention, as well as with respect to the 11 
length of the intervention and assessment point(s). 12 
Search strategy  13 
Initially, electronic databases MEDLINE, PubMed, PEDro, CINAHL, Cochrane Database of 14 
Clinical Trials, PsychINFO and Web of Science were searched for relevant articles up to July 15 
2017. A comprehensive search strategy was used. Key words ‘‘activity pacing’’ and ‘‘fatigue’’ 16 
were combined using an ‘‘and’’ statement. Key words related to physical activity (‘‘exercise,’’ 17 
“physical function,” ‘‘physical fitness,’’ ‘‘exercise therapy,’’ ‘‘activities of daily living,’’ 18 
‘‘therapeutic exercise,’’ ‘‘functional status,’’ and ‘‘rehabilitation”) were combined using an 19 
‘‘or’’ statement and then combined with the previous search using an ‘‘and’’ statement. The 20 
searches were limited to ‘‘English language,’’ ‘‘humans,’’ and ‘‘all aged 16 and older.’’ 21 
References and bibliographic lists of retrieved articles were also hand searched to find 22 
additional studies.  23 
Study selection and Data Extraction 24 
Two reviewers independently scanned all the titles and abstracts and identified potentially 25 
relevant articles to be retrieved using a custom-designed screening form. Where there was 26 
uncertainty, full-text copies of papers were obtained. Studies were considered eligible if they 27 
were randomized controlled trials; included patients with chronic conditions associated with 28 
fatigue complaints and assessed fatigue before and after intervention; involved activity pacing 29 
(activity pacing alone or in combination with psychosocial or exercise interventions [cognitive 30 
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behavioural therapy and/or graded exercise therapy]) program undertaken in a primary, 1 
secondary, or tertiary setting; and comprised a control group that did not receive any form of 2 
structured activity pacing but that could include usual or standard treatment. 3 
Outcomes included the following: fatigue, physical functioning and physical activity, assessed 4 
by recognized and validated measures. 5 
Two reviewers independently selected trials to be included: disagreements were resolved by 6 
consensus. Two reviewers independently extracted the data once the trials were formally 7 
included in the review. 8 
The following information was extracted from each selected study: 1) bibliographic 9 
information (authors, year of publication, country and reference); 2) type of chronic condition 10 
(chronic fatigue syndrome, fibromyalgia, other; 3) sample characteristics (sample size, gender, 11 
age); 4) provider (psychologist/psychotherapist, exercise physiologist, physical therapist, 12 
nurse, occupational therapist, other); 5) outcomes assessed (fatigue, physical activity, physical 13 
functioning); 6) measures used to assess outcomes (type and name of measure); and 7) 14 
assessment points (baseline, post-treatment — after the termination of the treatment, follow-up 15 
—an additional measurement taken at a later point in time after the termination of the trial); 8) 16 
type of care provided to the intervention group (activity pacing and/or graded exercise therapy 17 
and/or cognitive behavioural therapy); 9) type of care provided to the control group (passive 18 
control—waiting list control, treatment as usual, other; active control: relaxation/flexibility, 19 
counselling, other); 10) length of intervention and number of patient–provider sessions. Tables 20 
1 show the characteristics of the included studies.  21 
[Table 1 near here] 22 
Quality and risk of bias assessment 23 
The methodological quality of the included trials was assessed using a 14-item modified 24 
version of the Downs and Black checklist, [17]. The scale assesses characteristics of reporting, 25 
internal and external validity of trials. Each item is scored 0 (not done and/or not reported) or 26 
1 (done and/or reported). Total scores range from 0 to 14; higher scores indicate higher 27 
methodological quality. The Cochrane Collaboration’s tool for assessing risk of bias [18] was 28 
used to assess risk of bias in included studies. Risk of bias (high/low/uncertain) was classified 29 
based on the following items from this scale: Selection bias —random sequence generation and 30 
concealment of allocation; detection bias — blinding of participants and assessors; attrition 31 
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bias (incomplete outcome data) — information on attrition and inclusion of drop-outs in 1 
analyses and selective reporting. Discrepancies in quality rating were resolved by consensus 2 
between the two coders. Overall, inter-rater agreement on the items of the methodological 3 
quality and risk of bias scales was satisfactory (Cohen's kappa = 0.68)  4 
Data Synthesis 5 
Effect sizes were the standardized mean difference [(mean a −mean b / pooled change standard 6 
deviation)] with Hedge's g correction for small samples [19]. To calculate effect sizes for 7 
selected outcomes, we extracted sample sizes and baseline, post-treatment and/or follow-up 8 
means and standard deviations for the intervention and control groups. Authors of included 9 
studies were contacted when necessary to retrieve missing data in published reports. When 10 
reported in the original trials, we used data from intention-to-treat analyses. When several 11 
measures were used for the same outcome (e.g. physical functioning), we chose the measure 12 
most frequently used across the studies included. This was the case in one study [14], and in 13 
this instance the Checklist Individual Strength measure was used for the effect of the 14 
intervention on fatigue, as this was the tool most frequently used across the included studies. 15 
Data Analysis 16 
Analyses were conducted using the Review Manager (RevMan) Software Version 5.3 [20]. 17 
Main effects were calculated for each outcome (fatigue, physical activity and physical 18 
functioning) at post treatment and at follow-up. 19 
Main effects were weighted using the inverse variance method and aggregated using a random 20 
effects model, in which the summary effect is an estimate of the mean of a distribution of effect 21 
sizes [21]. Effect sizes were interpreted according to Cohen's guidelines (values of 0.20, 0.50 22 
and 0.80 correspond to small, medium and large effect sizes) [22]. The confidence intervals 23 
(CI) and corresponding p-values were considered as indicator of the significance of the effect. 24 
We also inspected the standardized residuals (i.e. how much each study differs from the overall 25 
effect) for outliers (1.96).  26 
We quantified between-study heterogeneity using I2 statistic [23] that assesses the proportion 27 
of observed dispersion that is due to real differences in the true effect sizes. The I2 ranges from 28 
0 to 100%, with values of 25%, 50% and 75% reflecting low, moderate and high heterogeneity 29 
[23]. Whenever heterogeneity of effect sizes was observed (I2 ≥50%), subgroup analyses were 30 
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conducted (where applicable) to examine whether effect sizes varied according to the potential 1 
moderators. 2 
Studies were grouped according to the following characteristics: i) activity pacing alone 3 
intervention vs. activity pacing combined with cognitive behavioural therapy and/or graded 4 
exercise therapy intervention; ii) minimal face-to-face individual/group patient(s)-provider 5 
contact (≤ 3sessions) vs. more contact (10sessions) and iii) fatigue-related condition vs. pain-6 
related condition. Between-groups Q statistic was used to compare the standardised mean effect 7 
post-treatment between subgroups, when there were at least three studies in each subgroup.  8 
Results  9 
Description of included studies 10 
A total of 79 potentially relevant articles were identified in the literature search and additional 11 
hand searches. The abstracts of all the articles were scanned to identify studies meeting the 12 
inclusion criteria. After the screening of abstracts 68 studies were excluded. Common reasons 13 
for exclusion were nonrandomized designs (n = 15), inappropriate interventions (n = 12), 14 
inappropriate sample groups (n = 28), and inappropriate outcome measures (n = 9). A total of 15 
11 full-text articles were retrieved. Three articles [24-26] were not intervention studies and one 16 
further study [27] did not include a control group and so were also excluded. Two articles 17 
reported data from the same study [13,28] and were therefore grouped together for analysis. 18 
Two authors of full articles were contacted to obtain additional data; however, only 1 provided 19 
the necessary data for inclusion [29]. This resulted in 6 studies [12-15,29,30] eligible for 20 
inclusion in the meta-analysis (table 1). The process of data screening is shown in figure 1.   21 
[Figure 1 near here] 22 
Study characteristics  23 
Three studies were activity pacing only and three were activity pacing combined with graded 24 
exercise therapy and/or cognitive behavioural therapy. The majority of the trials were 25 
conducted in Europe (the United Kingdom, the Netherlands and Belgium) (3 studies, 50%). 26 
The remaining studies were conducted in Australia (2 studies, 33%) and the United States of 27 
America (1 study, 17%), in secondary–tertiary care settings (e.g. specialized clinics). Study 28 
sample sizes varied widely from 32 to 319 patients (median, 54 patients), with a median 29 
intervention duration of 10 weeks (range, 2 to 23 weeks) and individual or group sessions 30 
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varied from 1-16 face to face contacts (median, 7.5). Post-treatment assessment points varied 1 
widely from 3 to 24 weeks and the follow-up assessment points was from 24 to 52 weeks. 2 
At baseline, the intervention group and the control group in the included studies were similar 3 
in terms of fatigue, physical functioning and physical activity (p  0.05). Reported baseline 4 
fatigue (mean and standard deviation or range) in the intervention groups and control groups 5 
were comparable across the studies. 6 
Assessment of outcome and measures 7 
Fatigue was the outcome measured in six trials, and was assessed with the Chalder Fatigue 8 
Scale [31] in two trials [15,30], the Checklist of Individual Strength [32] in one trial [12], while  9 
both the Checklist of Individual Strength and the Chronic Fatigue Syndrome Symptom List 10 
100 mm Visual Analogy Scale [32,33] were used in another trial [14]. Of the remaining trials, 11 
one [13] used the Brief Fatigue Inventory [34] to assess fatigue and the other [29] used the 12 
Somatic subscale of the Somatic and Psychological Health Report [35]. 13 
Physical functioning was reported in four studies, and the Short Form Health Survey-36 14 
physical function subscale [36] was used in three studies [14,15,29]. The Impact of Rheumatic 15 
Diseases on General Health and Lifestyle instrument [37] was used in the other study [12] to 16 
assess physical functioning. Of the two trials that reported physical activity [29,30] the Older 17 
Adult Exercise Status Inventory [38] was used in one trial [30], while the International Physical 18 
Activity Questionnaire [39] was used in the other trial [29].  19 
Three studies [14,13,30] had only post-treatment assessment points, while the remaining three 20 
studies [12,15,29] had both post-treatment and follow-up assessment points. 21 
Participant characteristics 22 
In total, 563 participants with chronic conditions associated with fatigue were included in this 23 
meta-analysis, with ages ranged from 16-74 years; approximately 82% were women. Patients 24 
with chronic fatigue syndrome diagnosed according to the Oxford [40] or the Centres for 25 
Disease Control and Prevention [41] criteria, were recruited in three trials. The essential 26 
characteristics of chronic fatigue syndrome according to the Oxford and the Centres for Disease 27 
Control and Prevention criteria are clinically evaluated, unexplained, persistent or relapsing 28 
fatigue not alleviated by rest and a cluster of symptoms that include chronic fatigue, sore throat, 29 
lymph node pain, post-exertional malaise, memory/concentration problems and unrefreshing 30 
sleep. The remaining trials recruited either exclusively post cancer fatigue patients diagnosed 31 
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with the Somatic subscale of the Somatic and Psychological Health Report [35] of which 1 
clinically-significant fatigue is an essential feature; or fibromyalgia patients diagnosed 2 
according to the American College of Rheumatology criteria [42] with the essential 3 
characteristics of unexplained, persistent widespread pain and symptoms of fatigue, cognitive 4 
problems and waking unrefreshed; or hip or knee osteoarthritis patients as evidenced by 5 
radiograph of osteoarthritis in that joint and a pain score of ≥ 4 out of the 5 items on the Western 6 
Ontario and McMaster Universities Osteoarthritis Index pain subscale [43]. 7 
Intervention characteristics 8 
In two studies [12,29], the intervention arm included activity pacing, cognitive behavioural 9 
therapy and graded exercise therapy.  The activity pacing intervention sought to encourage 10 
patients to avoid exacerbations of their symptoms by planning daily and weekly schedules of 11 
activities and rest breaks, and segmenting tasks into short time blocks. Cognitive behavioural 12 
therapy was aimed at diminishing the daily perceived cognitive, behavioural, emotional, and 13 
social consequences of illness and accompanying symptoms in order to optimize adherence to 14 
treatments. The graded exercise therapy component consisted of aerobic activities adapted to 15 
the individual’s physical capacity assessed at baseline taking into account a gradual increase in 16 
the duration and frequency of exercise sessions. The trials were delivered by clinical 17 
psychologists and exercise physiologists. The number of sessions ranged from 11 to 16 18 
sessions, weekly or fortnightly, lasting for 8-12 weeks. 19 
In one trial, the intervention group received graded exercise therapy incorporating a pacing 20 
construct, which consisted of individualized aerobic exercise based on baseline assessment and 21 
taking into account a gradual increase in the duration and intensity to reduce fatigue and 22 
increase activity [30]. Activity was gradually increased and rest was reduced, step by step as 23 
tolerance developed. Patients were recommended not to exceed the levels of exercise agreed 24 
upon beforehand by the therapist and patient, and to reduce their activity levels if symptoms 25 
got worse. The number of sessions was 12, once a week, lasting for 12 weeks, consisting of 1 26 
face-to-face and 6 telephone contacts. 27 
Two studies [13,14] included tailored activity pacing programs delivered via an educational 28 
module on activity pacing. The module outlined general principles of activity pacing as they 29 
apply to one’s condition and included the preplanning and prioritizing of activities, and 30 
alternating active and rest periods before a symptom exacerbation. Patients were advised to 31 
prevent over-activity. The focus was on a personalized report that summarized and visually 32 
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depicted each person’s symptom-activity relationship based on their physical activity and 1 
symptom data collected during a home monitoring period. Specific examples of where 2 
symptoms seemed to affect activity were highlighted within and across the days from the home 3 
monitoring period, and individual goals for pacing were formulated. The treatment also 4 
included an educational support manual and a log book to monitor coping strategies. The 5 
number of sessions ranged from 1 to 17 sessions, once or twice weekly, lasting for 3-10 weeks. 6 
The trial conducted by Kos et al., [14] consisted of a stabilization phase and a grading phase. 7 
The stabilization phase focused on coaching clients in how to perform activities of daily living 8 
within the limits of their actual capacity. The activity duration advised within the program was 9 
25%–50% below self-reported capacity, to account for any overestimations. Each activity 10 
block was interspersed with breaks, with the length of the break equating to the duration of the 11 
activity. Once clients were able to control their activities of daily living without excessive 12 
feelings of fatigue, the grading phase was started during which activity level was increased 13 
gradually. Participants conferred with a cognitive behavioural therapist to set relevant and 14 
achievable personal physical activity goals, based on prioritized activities. 15 
Adaptive pacing therapy was used in the trial by White et al., [15]. Therapeutic strategies 16 
consisted of identifying links between activity and fatigue by the use of a daily diary. Patients 17 
were encouraged to plan activities to avoid exacerbations, develop awareness of early warnings 18 
of exacerbation, limit demands and stress, regularly plan rest and relaxation, and alternate 19 
different types of activities, with advice not to undertake activities that required more than 70% 20 
of participants’ perceived energy envelopes. Increased activities were encouraged, if the 21 
participant felt able, and as long as they did not exacerbate symptoms. 22 
In summary, the theoretical models informing and guiding activity pacing intervention in the 23 
included studies are operant theory and energy conservation [44,45]. The operant theory-based 24 
interventions aimed to limit the extent to which activity is symptom-contingent (example, 25 
reduce excessive resting when fatigue or pain are high) in order to achieve predetermined 26 
activity goals [13,14,30]. The energy based interventions, on the other hand, sought to preserve 27 
energy for completing valued activities while reducing overall symptoms [12,15,29]     28 
Quality of the studies and risk of bias 29 
The Cochrane Collaboration’s tool for assessing risk of bias [18] was used to assess risk of bias 30 
in included studies. Methodological quality of each study was then assessed using a modified 31 
Downs and Black checklist, [17]. Table 2 shows the quality of the trials and risk of bias. The 32 
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trial by Sandler et al., [29] showed the highest quality and lowest risk of bias. The trial 1 
conducted by Wallman et al., [30] showed the lowest quality and presented an uncertain risk 2 
of bias on three criteria. The trials by van Koulil et al., [12] and Murphy et al., [13] presented 3 
uncertain risk of bias on two and three criteria respectively. The trial by Murphy et al., [13] 4 
presented a high risk of bias on selective reporting. In relation to attrition bias, most studies 5 
presented adequate drop-out information and inclusion (intent to treat analysis). Two trials 6 
[14,15] reported an adequate method of concealment, one presented high risk of bias [12] and 7 
two studies did not report details on blinding of assessors [18,30].  8 
[Table 2 near here] 9 
Synthesis of results 10 
Table 3 shows the overall results of the effect of activity pacing on fatigue, physical functioning 11 
and physical activity at post-treatment and/or follow-up. The forest plots of the effects 12 
comprising of the main effects are presented in figures 2, 3 and 4. Table 4 presents the results 13 
of the subgroup analysis of effects on fatigue for the post-treatment assessment.  14 
[Table 3 near here] 15 
[Table 4 near here] 16 
Effects on fatigue 17 
Six studies [12-15,29,30] reported measures of fatigue at post-treatment (varying from 3 to 24 18 
weeks). The pooled estimates showed moderate effect for fatigue at post-treatment 19 
(standardised mean difference = 0.49; 95% CI [0.08 – 0.90]) but results were heterogeneous 20 
between studies (I2 = 70) (table 3).  21 
Effects were larger when activity pacing was combined with graded exercise therapy or 22 
cognitive behavioural therapy (standardised mean difference = 0.68; 95% CI [0.28 – 1.08]) 23 
compared with activity pacing alone (standardised mean difference = 0.27; 95% CI [-0.12 – 24 
0.67]). The pooled estimate for the three studies which included minimal patient contact was 25 
moderate (standardised mean difference = 0.49; 95% C1 [0.14 – 0.85]) and homogeneous (I2 26 
= 0%) and was comparable in magnitude to the differences in interventions with more patient 27 
contact which was also moderate (standardised mean difference = 0.51; 95% CI [0.14 – 0.86]) 28 
but more heterogeneous (I2 = 87%) (table 4).  29 
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Three studies [12,15,29] presented fatigue data at follow up (varying from 24 to 52 weeks after 1 
baseline). The pooled estimates showed marginal effect for fatigue at follow-up (standardised 2 
mean difference = 0.37; 95% CI [-0.10 – 0.77]), but results were heterogeneous between studies 3 
(I2 = 71%) (table 3) The forest plots of effect sizes comprising the main effects of activity 4 
pacing on fatigue at both post-treatment and follow-up are illustrated in figure 2. 5 
[Figure 2 near here] 6 
Effects on physical functioning 7 
Four studies [12,14,15,29] reported measures of physical functioning at post-treatment (3–24 8 
weeks) and three studies [12,15,29] reported measures of physical functioning at follow-up 9 
(24–52 weeks). Combined effect sizes were inconsequential at post-treatment (standardised 10 
mean difference = 0.08; 95% CI [-0.36 – 0.51]) and at follow-up (standardised mean difference 11 
= d = -0.07; 95% CI [-0.61 – 0.48]), but effects varied between studies at both assessment 12 
points (I2 = 73% and I2 = 82% respectively) (table 3). The forest plots of effect sizes comprising 13 
the main effects of activity pacing on physical functioning at both post-treatment and follow-14 
up are illustrated in figure 3. 15 
[Figure 3 near here] 16 
Due to the limited number of studies presenting data for physical functioning no further 17 
potential moderator analyses were conducted.  18 
Effects on physical activity 19 
Post-treatment physical activity data (12 weeks) was available in only two studies [29,30]. 20 
Only one study [29] presented follow-up physical activity data (24 weeks). Overall main effect 21 
for physical activity at post-treatment was not significant (standardised mean difference = 0.30; 22 
95% CI [-0.08 – 0.68]), with evidence of homogeneity between studies (I2=0%) (table 3). For 23 
that reason, no further moderator analyses were conducted. The forest plots of effect sizes 24 
comprising the main effects of activity pacing on physical activity at post-treatment are 25 
illustrated in figure 4.  26 
 [Figure 4 near here] 27 
Sensitivity analyses 28 
Primary analyses were repeated with the exclusion of the trial by White et al. [15], which 29 
presented a high risk of bias and poor methodological quality (table 2). Excluding this study 30 
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led to an increase in the magnitude of treatment effects for fatigue at post-treatment from 1 
standardised mean difference = 0.50 to standardised mean difference = 0.67, and at follow-up 2 
from standardised mean difference = 0.34 to standardised mean difference = 0.51. And also led 3 
to an increase in the magnitude of treatment effects for physical functioning at post-treatment 4 
from standardised mean difference = 0.08 to standardised mean difference = 0.23, and at 5 
follow-up from standardised mean difference = -0.07 to standardised mean difference = -0.01 6 
The exclusion of the trial conducted by Wallman et al., [30] because of high/uncertain risk of 7 
bias in most categories and poor methodological quality, led to an increase in the overall point 8 
estimate for fatigue at post-treatment (from standardised mean difference = 0.50 to standardised 9 
mean difference = 0.52). Excluding both studies led to an increase in magnitude of treatment 10 
effects for fatigue at post-treatment from standardised mean difference = 0.50 to standardised 11 
mean difference = 0.75.  12 
Discussion 13 
To our knowledge, this is the first meta-analysis investigating the effectiveness of activity 14 
pacing on fatigue severity, physical functioning and physical activity in patients with fatigue 15 
complaints with or without a chronic condition. Six trials with baseline fatigue assessment and 16 
post treatment and/or follow-up assessment point(s) were included. In addition, this meta-17 
analysis analysed the potential moderating effects of the following trial characteristics at post-18 
treatment: whether the intervention arm was activity pacing only or activity pacing with 19 
behavioural and or exercise intervention and whether or not the intervention was a minimal 20 
(direct face to face) contact intervention. 21 
This meta-analysis shows that activity pacing interventions have beneficial effects on fatigue 22 
at post-treatment (standardised mean difference = 0.50) and marginal effect at follow-up 23 
(standardised mean difference = 0.34) in chronically fatiguing conditions. Treatment effects 24 
varied widely between studies and subsequent subgroup comparisons revealed that components 25 
of intervention arm and amount of face-to-face contact were not significant moderators of the 26 
effect of the interventions on fatigue at post-treatment. The effect of minimal contact 27 
interventions on fatigue (standardised mean difference = 0.49) was comparable in magnitude 28 
to the effect of interventions of more intensive contact (standardised mean difference = 0.51). 29 
The finding is somewhat similar to that of a recent meta-analysis on effects of behavioural and 30 
psychological interventions that pointed at the beneficial effects of minimal contact 31 
interventions on fatigue [46]. This makes a case for activity pacing as a plausible effective less 32 
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resource intensive activity stimulation program that could substitute for more resource 1 
intensive programs such as cognitive-behavioural therapy and can be useful for patients 2 
presenting difficulties in regularly attending health care facilities [47]. The lack of sustained 3 
beneficial effect at follow-up may be accounted for by the limited number of studies providing 4 
follow-up fatigue data. This highlights the need for future interventional studies on the long-5 
term effect of activity pacing on fatigue. 6 
Furthermore, the overall effect sizes for intervention arms comprising of activity pacing 7 
combined with cognitive behavioural therapy and/or graded exercise therapy on fatigue were 8 
larger (effect size = 0.68) than intervention arms of activity pacing alone (effect size = 0.27). 9 
It is however important to point out that of the studies included in our meta-analysis, only three 10 
studies were activity pacing alone interventions, each of them with clearly distinct features. 11 
One trial, was a tailored activity pacing intervention that focused on preplanning and 12 
prioritizing of activities, and alternating active and rest periods before a symptom exacerbation 13 
[13], another was an activity pacing trial that focussed on prioritizing of activities, and 14 
alternating active and rest periods, and  gradually increasing activities to prevent exacerbation 15 
of symptom [14], and the last one was the adaptive pacing trial that restricted performance of 16 
activities within limits of 70% of actual capacity [15]. The high heterogeneity found in this 17 
subgroup and the limited number of trials is a limitation to this finding. This suggests that there 18 
may differences in the effect of activity pacing interventions on fatigue across other particular 19 
patient characteristics such as disease diagnosis, attitude towards physical activity, self-20 
efficacy and stage of behavioural change. Further exploratory studies on this is needed. 21 
Regarding physical function, inconsequential main treatment effects of activity pacing were 22 
found post-treatment (standardised mean difference = 0.08) and at follow-up (standardised 23 
mean difference = -0.07). However, considerable variation in response was observed at both 24 
assessment points. The small number studies included in this meta-analyses that reported 25 
activity pacing effects on physical functioning limited further analyses of potential moderators 26 
of the variance in activity pacing main effect. This points to the fact that there may be 27 
differences in the effect of activity pacing interventions on physical functioning across other 28 
particular patient and/or intervention characteristics. More research is clearly needed to analyse 29 
the effects potential moderators.  30 
Considering that activity pacing instruction directly relates to altering physical activity 31 
patterns, it was interesting to find that only a handful of studies (n = 2) evaluated the effect of 32 
15 
 
activity pacing on physical activity in patients with high fatigue complaints. Although a small 1 
non-significant main effect (standardised mean difference = 0.30) of activity pacing on physical 2 
activity was found in this review, the responses were varied. The limited number of included 3 
studies reporting on the effect of activity pacing on physical activity could account for the small 4 
treatment effect found in this review is a limitation to this finding. Previous exploration into 5 
the effects of activity pacing on physical activity has produced inconsistent findings. In some 6 
studies, pacing was associated with lower levels of physical activity [12,13], while in other 7 
studies pacing was related to high physical activity [24,25,44].  8 
These inconsistencies may in part be explained by study design and interpretation of AP as 9 
observed in this review. While some studies described activity pacing as managing energy 10 
expenditure, aimed at staying within boundaries of physical limits by either focusing on 11 
symptoms or by including rest [13,15,29], other studies included activity progression as an aim 12 
of activity pacing [12,14,29]. This highlights the dearth of a standardized definition of activity 13 
pacing and may reflect the ineffectiveness of activity pacing if not used to gradually increase 14 
an individual’s activity level [10]. 15 
Other features that could have moderated the findings are avoidance behaviour, naturalistic 16 
pacing behaviour (level of activity pacing that persons implement in daily life without a 17 
specifically instructed activity pacing program) and perceived difficulty in preventing over-18 
activity in daily life. With most of the studies aimed at preventing over-activity [13,15,29], 19 
superior improvement may have been observed in persons with high natural engagement in 20 
pacing and/or high perceived difficulty in preventing over-activity compared to persons with 21 
avoidance behaviour, low natural engagement in pacing and/or low perceived difficulty in 22 
preventing over-activity. Future studies exploring the impact of patients behaviour towards 23 
physical activity is of utmost importance. 24 
The discrepancy that was found in this meta-analysis between the effects found for fatigue and 25 
for physical activity and physical functioning could indicate that the mere decrease of fatigue 26 
does not necessary lead to improved outcomes in terms of physical activity and physical 27 
functioning. This may point at the fact that alternative ways of promoting physical activity and 28 
physical functioning, e.g. flexibility in physical activity goals in the form of tailoring advice to 29 
individual’s characteristics towards physical activity assessed at baseline and making use of 30 
motivational interview may be more successful in changing this health behaviour and equally 31 
16 
 
managing fatigue. This provide further insight to help optimize tailored activity stimulation 1 
programs. 2 
Limitations and recommendations for future research 3 
The limited number of eligible and included studies, coupled with the uneven distribution of 4 
studies in subgroups limited the analyses of subgroups effect sizes of activity pacing on fatigue, 5 
physical functioning and physical activity. Readers should therefore be cautious when 6 
interpreting the pooled effect sizes. Emphasis should instead be placed on the distribution in 7 
each category and the observed patterns in the data. Future studies should continue to explore 8 
potential moderators that can account for differences between trial results. Among these are 9 
patient and disease-related characteristics (e.g. illness duration, severity of disease, attitudes 10 
towards pacing) and treatment features (e.g. pacing alone, pacing + graded activity).  11 
Most of the categorization of intervention characteristics was based on the intervention 12 
description provided in the articles. In many cases these descriptions were limited and the same 13 
accounts for the description of the content of manuals that were used in different interventions. 14 
Future studies should give a sufficiently detailed account of the content of the intervention/self-15 
help manual offered to patients. Although most of the outcomes were assessed using validated 16 
measures, the way scores were calculated was not always clear. Future randomized controlled 17 
trials should pay more attention to the way statistical data are presented, making an effort to 18 
present effect sizes and raw data (means and standard deviations) for all outcomes and 19 
assessment periods. 20 
The number of studies included in this meta-analysis that presented follow-up assessment data 21 
was limited and only available for a maximum period of 52 weeks. Hence, although activity 22 
pacing had sustainable beneficial effects on fatigue management and small effects on physical 23 
functioning after data synthesis, more research is needed to understand long-term effects. More 24 
research on the impact of activity pacing on physical activity behaviour using subjective and 25 
objective measures are needed.  26 
There is the need to standardize activity pacing based on a clear theoretical concept and 27 
consideration of the context in which the behaviour occurs. There is also a need for further 28 
validity studies of measures of activity pacing to help streamline the construct. Additionally, 29 
studies on the effect of natural pacing behaviour and perceive difficulty in preventing 30 
overactivity on the effectiveness of pacing intervention are needed to help guide and refine 31 




This meta-analysis of activity pacing in patients with chronic diseases associated with fatigue 2 
complaints suggests that activity pacing might have sustained beneficial effects on fatigue 3 
management, in particular on fatigue reduction for which small-to-moderate effects were 4 
found. The finding that minimal contact interventions had similar effect compared to more 5 
intensive contact intervention is important. This provides valuable insight that activity pacing 6 
intervention can be feasibly implemented in standard health care and can be suitable for patients 7 
who do not need more intensive forms of treatment.  8 
More importantly, findings of the study demonstrate the need to further explore moderators 9 
such as patient’s behaviour towards physical activity assessed at baseline to help optimize the 10 
tailoring of activity stimulation programs. All trials included in this meta-analysis had an initial 11 
face-to-face patient-provider contact with patients, which may have led to increased motivation 12 
of patients to engage in a behaviour change process. Notwithstanding the beneficial effects of 13 
activity pacing reported in this meta-analysis and the valuable indications about targets and 14 
format of future interventions, more research are needed to identify optimal features of activity 15 
pacing. 16 
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List of Figure Captions 23 
Figure. 1. Flow diagram of data screening. 24 
Figure 2. Forest plot of the activity pacing effects on fatigue at (A) post-treatment and (B) 25 
follow-up. The pooled SMD was .50 (95% CI [.14 – .86]) at post-treatment. The pooled SMD 26 
was .34 (95% CI [-.01 – .77]) at follow-up. 27 
Figure 3. Forest plot of the activity pacing effects on physical functioning at (C) post-28 
treatment and (D) follow-up. The pooled SMDs was .08 (95% CI [-.36 – .51]) at post-29 
treatment. The pooled SMD was -.07 (95% CI [-.61 – .48]) at follow-up. 30 
Figure 4. Forest plot of the activity pacing effects on physical activity for post-treatment. The 31 
pooled SMD was .30 (95% CI [-.08 – .68]) at post-treatment. 32 
21 
 
Table1. Characteristics of Included studies  
Study   
Intervention Led 
Sample size (Male/Female) 
Age in years (Mean ±SD)  
Condition Diagnosis  
Intervention Condition  
(Control condition) 
Structure of Session  & 
Assessment (weeks) 
Measure tool Outcome 
Van Koulil et al., [12]  
Cognitive Behavioural 
Therapist 
84 (6/78)  
41.7 ± 10.9  
Fibromyalgia 
Pacing + CBT + GET  
(Waiting List) 
16 group sessions/2x8 
weeks + 1 booster session 
Post-treatment = 10             




Physical function  
Wallman et al., [30]   
Physiologist 
61 (14/47)  
NA(16-74)  
Chronic Fatigue Syndrome 
Pacing + GET   
 
(Relaxation/flexibility) 
1 face to face session + 6 
telephone calls/12 weeks  
Post-treatment = 12 
Chalder Fatigue 
Questionnaire 
Older Adult Exercise 
Status Inventory                       
Fatigue  
 
Physical activity  
Sandler et al., [29] 
Clinical psychologist  
Exercise physiologist 
46 (3/43) 
51.2 ± 9.5 
Post Cancer Fatigue 
Pacing + CBT + GET                         
 
(Education) 
11-13 face to face 
sessions/12weeks         
Post-treatment = 12              
Follow-up = 24 




Physical function  
Physical activity  
Kos et al., [14]  
Occupational Therapist 
33 (0/33)       
39.3 ± 11.4  40.8 ± 11.1  
Chronic Fatigue Syndrome 
Tailored Pacing         
(Relaxation) 
 
3 face to face/1x3 weeks            
Post-treatment = 3 
CIS & CFSSL                             
Short Form Physical 
Function subscale             
Fatigue 
Physical function  
Murphy et al., [13] 
Occupational Therapist 
32 (8/24)       
61.9 ± 7.9  
Hip/Knee Osteoarthritis 
Tailored  Pacing    
(General Pacing) 
2 face to face/1x2 weeks 




White et al., [15]  
Occupational Therapist 
319 (76/243)    
38 ± 12  
Chronic Fatigue Syndrome 
Adaptive Pacing + 
Specialist Medical Care 
(Specialist Medical Care) 
14 face to face and 
telephone / 23 weeks  
Post-treatment = 24              
Follow-up = 52 
Chalder Fatigue 
Questionnaire 






CBT: Cognitive Behavioural Therapy  CIS: Checklist Individual Strength             CFSSL: Chronic Fatigue Syndrome Symptom List        
GET: Graded Exercise Therapy               IRGL: Impact of Rheumatic Diseases on General Health and Lifestyle Instrument                           
 
Table 2:  Classification on methodological quality, risk of bias and moderators of included interventions. 
Study ID Methodological 




















van Koulil et al., [12] 13 Low  High Unclear Unclear  Low  Low  Low 
Wallman et al., [30] 11 Low  Unclear Unclear  Unclear  Low  Low  Low 
Sandler et al., [29] 13 Low Low Low Low Low Low Low 
Kos et al., [14] 11 Low  Low Unclear  Low  Low  Low  Low  
Murphy et al., [13] 12 Unclear  Unclear Unclear  Low  Low  High  Low 










Table 3: Pooled mean estimates for change in outcomes assessed at post-treatment and at follow-up. 
Outcome Assessment point k n Standardised Mean Difference [95%CI] Z p I2 
Fatigue 
Post-treatment 6 563 0.50 [0.14, 0.86] 2.69 0.007 70% 
Follow-up 3 435 0.34 [-0.10, 0.77] 1.53 0.13 71% 
Physical 
functioning 
Post-treatment 4 470 0.08 [-0.36, 0.51] 0.35 0.73 73% 
Follow-up 3 435 -0.07 [-0.61, 0.48] 0.24 0.81 82% 
Physical activity 
Post-treatment 2    107 0.30 [-0.08, 0.68] 0.44 0.66 0% 
Follow-up 1 46 n/a n/a n/a n/a 











Table 4: Subgroup analysis assessing the effect of study characteristics upon fatigue at post-treatment. 
Moderator Fatigue 




GET + CBT 
3 0.68 [0.28, 1.08] 3.35 (p = 0.0008)  
p = 0.16  I² =50.3% 
I² = 44% (p=0.17) 






3 0.49 [0.14, 0.85]  2.72 (p = 0.007)  
p = 0.96  I² = 0% 
I² = 0% (p=0.91) 
More contact 3 0.51 [-0.14, 1.17]  1.53 (p = 0.13) I² = 87% (p=0.0005) 
Condition Fatigue-
related 
4 0.28 [-0.01, 0.56]  1.90 (p = 0.06)  
n/a 
I² = 36% (p=0.19) 
Pain-related  2 0.49 [0.49, 1.30]  4.36 (p < 0.0001) I² = 6% (p=0.30) 
CBT = Cognitive Behavioural Therapy; GET = Graded Exercise Therapy; k = number of studies; p1 = p-Values correspond to subgroup differences 
































18 additional records identified 
through other sources 
 
5 Full-text articles excluded 
*Repeated data (n=1) 
*Not randomised control trial / No 
control group (n=1) 
*Did not include activity pacing as 
an intervention (n=3) 
68 records excluded 79 records screened 
11 full-text articles assessed 
for eligibility and reviewed 
 
6 studies were included in 
the final analysis 
 
271 records identified through 
database searching 
 








Figure 2. Forest plot of the activity pacing effects on fatigue at (A) post-treatment and (B) follow-up. The pooled SMD was .50 (95% CI [.14 – 








Figure 3. Forest plot of the activity pacing effects on physical functioning at (C) post-treatment and (D) follow-up. The pooled SMDs was .08 




Figure 4. Forest plot of the activity pacing effects on physical activity for post-treatment. The pooled SMD was .30 (95% CI [-.08 – .68]) at post-
treatment. 
 
 
